KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Buildings (2016 - 2024)

Historic Buildings for Abbott Laboratories (ABT) over the last 16 years, with Q4 2024 value amounting to $4.2 billion.

  • Abbott Laboratories' Buildings rose 110.55% to $4.2 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $4.2 billion, marking a year-over-year increase of 110.55%. This contributed to the annual value of $4.2 billion for FY2024, which is 110.55% up from last year.
  • Latest data reveals that Abbott Laboratories reported Buildings of $4.2 billion as of Q4 2024, which was up 110.55% from $4.2 billion recorded in Q4 2023.
  • Abbott Laboratories' 5-year Buildings high stood at $4.2 billion for Q4 2024, and its period low was $4.0 billion during Q4 2021.
  • Its 5-year average for Buildings is $4.1 billion, with a median of $4.1 billion in 2022.
  • Per our database at Business Quant, Abbott Laboratories' Buildings surged by 842.79% in 2020 and then fell by 17.44% in 2021.
  • Over the past 5 years, Abbott Laboratories' Buildings (Quarter) stood at $4.0 billion in 2020, then fell by 0.17% to $4.0 billion in 2021, then rose by 1.15% to $4.1 billion in 2022, then grew by 2.66% to $4.2 billion in 2023, then grew by 1.11% to $4.2 billion in 2024.
  • Its Buildings stands at $4.2 billion for Q4 2024, versus $4.2 billion for Q4 2023 and $4.1 billion for Q4 2022.